Product Overview
Mircera 75 Micrograms 0.3ml Injection is a medication used to treat anemia in patients with chronic kidney disease or cancer who are receiving chemotherapy. It belongs to a class of drugs known as erythropoiesis-stimulating agents, which work by helping the body produce more red blood cells.

Key Benefits
- Effective treatment for anemia
- Helps increase red blood cell production
- Long-acting formulation reduces frequency of injections
- Suitable for patients with chronic kidney disease or cancer

How It Works
Mircera contains Methoxy Polyethylene Glycol-Epoetin Beta, which is a synthetic form of erythropoietin. Erythropoietin is a hormone produced by the kidneys that stimulates the bone marrow to produce red blood cells. By mimicking the action of natural erythropoietin, Mircera helps increase red blood cell production and improve symptoms of anemia.

Directions for Use
- Mircera is typically administered by injection under the skin or into a vein by a healthcare professional.
- The dosage and frequency of injections will be determined by your doctor based on your condition and response to treatment.
- Follow all instructions provided by your healthcare provider and do not self-administer this medication.

Precautions
- Inform your doctor about any allergies or medical conditions you have before using Mircera.
- Do not use Mircera if you have uncontrolled high blood pressure or a history of blood clots.
- Monitor your blood pressure regularly while using this medication.

Storage Instructions
- Store Mircera in the refrigerator between 36-46 degrees Fahrenheit (2-8 degrees Celsius).
- Do not freeze Mircera, and protect it from light.
- Keep Mircera out of reach of children and pets.

Manufacturer Information
Mircera is manufactured by Roche, a leading pharmaceutical company known for producing high-quality medications. Roche is committed to improving patient outcomes and advancing medical research to address unmet healthcare needs.